Goldman Sachs upgrades our Target Price from $2.6 to $3.0 (15%).Estimated EBITDA:2022 - 174 mil2023 - 195 mil2024 - 225 milCould we hold $3 even if IGO is not bidding?
EMV EMVision Medical successfully fabs first prototype of First Responder brain scan device – portable enough for a backpack
ARU Arafura updates on total US$1B funding as export banks and lenders take notice; heading toward FID for Nolans
ITM iTech Minerals flags high-grade rockchip finds, boasting one sample at +18% copper. What lies underground remains to be seen